These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25522002)

  • 1. Fatty liver disease, glucose tolerance and insulin resistance in obese adolescents.
    Slyper AH; Rosenberg H; Kabra A; Huang WM; Blech B; Matsumura MM
    Pediatr Obes; 2015 Dec; 10(6):423-7. PubMed ID: 25522002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early atherogenesis and visceral fat in obese adolescents.
    Slyper AH; Rosenberg H; Kabra A; Weiss MJ; Blech B; Gensler S; Matsumura M
    Int J Obes (Lond); 2014 Jul; 38(7):954-8. PubMed ID: 24451186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage.
    Giannini C; Feldstein AE; Santoro N; Kim G; Kursawe R; Pierpont B; Caprio S
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2993-3000. PubMed ID: 23626003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese Hispanic adolescents.
    Kim JS; Lê KA; Mahurkar S; Davis JN; Goran MI
    Pediatr Obes; 2012 Apr; 7(2):158-64. PubMed ID: 22434756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H-MRS Measured Ectopic Fat in Liver and Muscle in Danish Lean and Obese Children and Adolescents.
    Fonvig CE; Chabanova E; Andersson EA; Ohrt JD; Pedersen O; Hansen T; Thomsen HS; Holm JC
    PLoS One; 2015; 10(8):e0135018. PubMed ID: 26252778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents.
    van der Heijden GJ; Wang ZJ; Chu ZD; Sauer PJ; Haymond MW; Rodriguez LM; Sunehag AL
    Obesity (Silver Spring); 2010 Feb; 18(2):384-90. PubMed ID: 19696755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.
    Umpaichitra V; Banerji MA; Castells S
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):853-64. PubMed ID: 15270403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive sleep apnoea in obese adolescents and cardiometabolic risk markers.
    Watson SE; Li Z; Tu W; Jalou H; Brubaker JL; Gupta S; Huber JN; Carroll A; Hannon TS
    Pediatr Obes; 2014 Dec; 9(6):471-7. PubMed ID: 24106092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous and total fat at L4-L5 and subcutaneous, visceral and total fat at L3-L4 are important contributors of fasting and postprandial adiponectin levels.
    Katergari SA; Passadakis P; Milousis A; Passadaki T; Asimakopoulos B; Mantatzis M; Prassopoulos P; Tripsianis G; Nikolettos N; Papachristou DN
    Endocr Res; 2015; 40(3):127-32. PubMed ID: 25774471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term weight-loss therapy.
    Campos RMDS; Masquio DCL; Corgosinho FC; Caranti DA; Ganen AP; Tock L; Oyama LM; Dâmaso AR
    Diab Vasc Dis Res; 2019 Mar; 16(2):196-206. PubMed ID: 30688518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
    Eriksson JW; Jansson PA; Carlberg B; Hägg A; Kurland L; Svensson MK; Ahlström H; Ström C; Lönn L; Ojbrandt K; Johansson L; Lind L
    Hypertension; 2008 Dec; 52(6):1030-7. PubMed ID: 18981327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low visceral fat proportion, independent of total body fat mass, protects obese adolescent girls against fatty liver and glucose dysregulation: a longitudinal study.
    Umano GR; Shabanova V; Pierpont B; Mata M; Nouws J; Tricò D; Galderisi A; Santoro N; Caprio S
    Int J Obes (Lond); 2019 Apr; 43(4):673-682. PubMed ID: 30337653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.
    Burgert TS; Taksali SE; Dziura J; Goodman TR; Yeckel CW; Papademetris X; Constable RT; Weiss R; Tamborlane WV; Savoye M; Seyal AA; Caprio S
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4287-94. PubMed ID: 16912127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
    Levelt E; Pavlides M; Banerjee R; Mahmod M; Kelly C; Sellwood J; Ariga R; Thomas S; Francis J; Rodgers C; Clarke W; Sabharwal N; Antoniades C; Schneider J; Robson M; Clarke K; Karamitsos T; Rider O; Neubauer S
    J Am Coll Cardiol; 2016 Jul; 68(1):53-63. PubMed ID: 27364051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
    Kim JY; Michaliszyn SF; Nasr A; Lee S; Tfayli H; Hannon T; Hughan KS; Bacha F; Arslanian S
    Diabetes Care; 2016 Aug; 39(8):1431-9. PubMed ID: 27293201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.
    Ravikumar B; Gerrard J; Dalla Man C; Firbank MJ; Lane A; English PT; Cobelli C; Taylor R
    Diabetes; 2008 Sep; 57(9):2288-95. PubMed ID: 18535187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.